Tabuk pharmaceuticals is one of the leading providers for high quality well trusted medications in many different therapeutic areas all over the MENA region
Being known of its Diverse Cardio-metabolic range, tabuk strives to enable it's partners in healthcare sector to access effective new solutions, and drugs that can make life better.
In Sudan tabuk has been established as a local factory participating effectively in fulfillment of Availability, Affordability, and Quality.
Varoxa (Rivaroxaban) is the new novel oral anticoagulant (NOAC) provided for the first time in Sudan that will enable (Better Life for our People and Patients)
its Efficacy and safety in Stroke prevention in NVAF patients, PE and DVT, can dramatically enhance medical outcomes.
Varoxa (Rivaroxaban) is Provided in 3 dosages (10mg-15mg-20mg)
